Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,558,760
-
Share change
-
-5,524,949
-
Total reported value
-
$459,803,569
-
Put/Call ratio
-
316%
-
Price per share
-
$17.99
-
Number of holders
-
123
-
Value change
-
-$91,536,131
-
Number of buys
-
60
-
Number of sells
-
51
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q4 2020
As of 31 Dec 2020,
G1 THERAPEUTICS INC - COM (GTHX) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,558,760 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, MPM ONCOLOGY IMPACT MANAGEMENT, L.P., MPM Oncology Impact Management LP, WELLINGTON MANAGEMENT GROUP LLP, GOLDMAN SACHS GROUP INC, and FMR LLC.
This page lists
123
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.